# Aardvark Therapeutics, Inc.: filings AARD · Nasdaq · CIK 1774857 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/aard.md) · [Financials](/companies/aard/financials.md) · [Filings](/companies/aard/filings.md) · [Insiders](/companies/aard/insiders.md) ## Reports and events: 35 filings Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 31, 8-K 25, 3 12, 10-Q 5, 144 5, CORRESP 4, SCHEDULE 13G 4, D 3, S-8 3, UPLOAD 3, 10-K 2, DRS/A 2, DRSLTR 2, EFFECT 2, 424B4 1, 424B5 1, 8-A12B 1, ARS 1, CERT 1, DEF 14A 1, DRS 1, PRE 14A 1, S-1 1, S-1/A 1, S-3 1). | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 12:38 ET | [8-K](/filings/0001193125-26-429509.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-429509 | | 2026-10-22 | 20:17 ET | [8-K](/filings/0001193125-26-428943.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-428943 | | 2026-10-08 | 20:14 ET | [8-K](/filings/0001193125-26-417935.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-417935 | | 2026-08-17 | 20:10 ET | [8-K](/filings/0001193125-26-354053.md) | 5.07 Shareholder vote results | 0001193125-26-354053 | | 2026-08-11 | 21:09 ET | [10-Q](/filings/0001193125-26-344987.md) | Quarterly report, period 2026-06-30 | 0001193125-26-344987 | | 2026-08-11 | 21:05 ET | [8-K](/filings/0001193125-26-344978.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344978 | | 2026-07-10 | 20:05 ET | [DEF 14A](/filings/0001193125-26-300874.md) | Proxy statement, period 2026-08-14 | 0001193125-26-300874 | | 2026-06-12 | 20:05 ET | [8-K](/filings/0001193125-26-269377.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-269377 | | 2026-05-14 | 20:15 ET | [8-K](/filings/0001193125-26-224069.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-224069 | | 2026-05-07 | 13:32 ET | [10-Q](/filings/0001193125-26-210675.md) | Quarterly report, period 2026-03-31 | 0001193125-26-210675 | | 2026-05-07 | 13:28 ET | [8-K](/filings/0001193125-26-210664.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210664 | | 2026-03-24 | 22:30 ET | [8-K](/filings/0001193125-26-120164.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-120164 | | 2026-03-23 | 20:19 ET | [10-K](/filings/0001193125-26-119770.md) | Annual report, period 2025-12-31 | 0001193125-26-119770 | | 2026-03-23 | 20:09 ET | [8-K](/filings/0001193125-26-119727.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-119727 | | 2026-02-27 | 21:27 ET | [8-K](/filings/0001193125-26-082787.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-082787 | | 2026-02-12 | 13:17 ET | [8-K](/filings/0001193125-26-047757.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-047757 | | 2026-02-10 | 13:14 ET | [8-K](/filings/0001193125-26-043764.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-043764 | | 2026-01-12 | 13:30 ET | [8-K](/filings/0001193125-26-009862.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009862 | | 2025-12-10 | 21:54 ET | [8-K](/filings/0001193125-25-314364.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-314364 | | 2025-11-13 | 21:29 ET | [10-Q](/filings/0001193125-25-280260.md) | Quarterly report, period 2025-09-30 | 0001193125-25-280260 | | 2025-11-13 | 21:20 ET | [8-K](/filings/0001193125-25-280235.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-280235 | | 2025-11-06 | 23:11 ET | [8-K](/filings/0001193125-25-267402.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-267402 | | 2025-11-04 | 21:19 ET | [8-K](/filings/0001193125-25-264748.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-264748 | | 2025-10-09 | 21:45 ET | [8-K](/filings/0001193125-25-234722.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-234722 | | 2025-09-03 | 00:56 ET | [8-K](/filings/0000950170-25-112645.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-112645 | | 2025-08-13 | 20:47 ET | [10-Q](/filings/0000950170-25-108116.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108116 | | 2025-08-13 | 20:34 ET | [8-K](/filings/0000950170-25-108082.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108082 | | 2025-08-12 | 20:11 ET | [8-K](/filings/0000950170-25-107320.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-107320 | | 2025-05-14 | 20:50 ET | [10-Q](/filings/0000950170-25-071560.md) | Quarterly report, period 2025-03-31 | 0000950170-25-071560 | | 2025-05-14 | 20:27 ET | [8-K](/filings/0000950170-25-071477.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-071477 | | 2025-03-31 | 20:45 ET | [10-K](/filings/0000950170-25-047835.md) | Annual report, period 2024-12-31 | 0000950170-25-047835 | | 2025-03-31 | 20:21 ET | [8-K](/filings/0000950170-25-047769.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-047769 | | 2025-02-14 | 21:01 ET | [8-K](/filings/0001193125-25-027245.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-027245 | | 2025-02-06 | 21:02 ET | [S-1/A](/filings/0001193125-25-021764.md) | Registration statement, amended | 0001193125-25-021764 | | 2025-01-23 | 21:57 ET | [S-1](/filings/0001193125-25-011499.md) | Registration statement | 0001193125-25-011499 | Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.